About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.

Articles

SGLT2 Inhibitors and HF Prevention

Published:

04 November 2019

Citation:

Cardiac Failure Review 2019;5(3):169–72.